| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |